The Cigna Group (NYSE:CI) Shares Sold by Ascent Group LLC

Ascent Group LLC decreased its position in shares of The Cigna Group (NYSE:CIFree Report) by 79.3% during the 1st quarter, HoldingsChannel reports. The fund owned 1,660 shares of the health services provider’s stock after selling 6,378 shares during the quarter. Ascent Group LLC’s holdings in The Cigna Group were worth $603,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Seizert Capital Partners LLC boosted its position in shares of The Cigna Group by 195.8% during the 4th quarter. Seizert Capital Partners LLC now owns 32,150 shares of the health services provider’s stock valued at $9,627,000 after acquiring an additional 21,280 shares during the last quarter. Roman Butler Fullerton & Co. boosted its position in shares of The Cigna Group by 61.4% during the 4th quarter. Roman Butler Fullerton & Co. now owns 9,307 shares of the health services provider’s stock valued at $2,772,000 after acquiring an additional 3,539 shares during the last quarter. TFO Wealth Partners LLC raised its holdings in The Cigna Group by 98,980.0% in the 4th quarter. TFO Wealth Partners LLC now owns 4,954 shares of the health services provider’s stock valued at $1,497,000 after buying an additional 4,949 shares during the period. Sapient Capital LLC purchased a new stake in The Cigna Group in the 4th quarter valued at about $2,811,000. Finally, Allspring Global Investments Holdings LLC raised its holdings in The Cigna Group by 29.5% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 293,438 shares of the health services provider’s stock valued at $87,870,000 after buying an additional 66,891 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

CI has been the topic of several research analyst reports. Oppenheimer boosted their price objective on shares of The Cigna Group from $370.00 to $400.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. Baird R W upgraded shares of The Cigna Group to a “strong-buy” rating in a report on Thursday, May 30th. Robert W. Baird initiated coverage on shares of The Cigna Group in a report on Thursday, May 30th. They issued an “outperform” rating and a $388.00 price objective on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $400.00 price objective on shares of The Cigna Group in a report on Wednesday, July 10th. Finally, Piper Sandler began coverage on shares of The Cigna Group in a research note on Wednesday, June 26th. They set an “overweight” rating and a $400.00 price target on the stock. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $376.20.

Check Out Our Latest Report on CI

Insider Activity at The Cigna Group

In related news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the company’s stock in a transaction that occurred on Tuesday, May 14th. The stock was sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the transaction, the senior vice president now directly owns 2,595 shares of the company’s stock, valued at $904,902.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Brian C. Evanko sold 4,795 shares of the stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $345.01, for a total value of $1,654,322.95. Following the completion of the sale, the insider now directly owns 39,923 shares of the company’s stock, valued at $13,773,834.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the sale, the senior vice president now directly owns 2,595 shares of the company’s stock, valued at $904,902.45. The disclosure for this sale can be found here. Insiders sold 22,988 shares of company stock valued at $7,975,726 over the last three months. 0.60% of the stock is owned by corporate insiders.

The Cigna Group Stock Up 1.8 %

Shares of The Cigna Group stock traded up $6.29 on Tuesday, reaching $352.83. 251,062 shares of the company were exchanged, compared to its average volume of 1,551,166. The Cigna Group has a 1-year low of $253.95 and a 1-year high of $365.71. The company has a market cap of $100.23 billion, a P/E ratio of 28.46, a price-to-earnings-growth ratio of 1.05 and a beta of 0.52. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.71 and a quick ratio of 0.71. The stock’s 50 day moving average price is $335.24 and its 200-day moving average price is $338.14.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The health services provider reported $6.47 EPS for the quarter, topping analysts’ consensus estimates of $6.17 by $0.30. The Cigna Group had a return on equity of 17.24% and a net margin of 1.76%. The business had revenue of $57.25 billion during the quarter, compared to the consensus estimate of $56.59 billion. During the same period in the previous year, the company posted $5.41 earnings per share. The business’s revenue for the quarter was up 23.2% on a year-over-year basis. As a group, equities analysts forecast that The Cigna Group will post 28.47 EPS for the current year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 19th. Investors of record on Wednesday, September 4th will be issued a $1.40 dividend. This represents a $5.60 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date is Wednesday, September 4th. The Cigna Group’s dividend payout ratio (DPR) is 45.98%.

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Read More

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.